University Pharmaceuticals of Maryland

UPM Pharmaceuticals is a contract development and manufacturing organization (CDMO) that specializes in the development and production of solid oral and semi-solid drug products. Originally founded as University Pharmaceuticals of Maryland, a spin-out from the University of Maryland School of Pharmacy, the company provides comprehensive services from early-stage formulation to commercial-scale manufacturing. UPM operates a large-scale, cGMP-compliant facility in Bristol, Tennessee, which was acquired to expand its production capacity. The company serves a diverse client base ranging from small virtual biotech firms to large multinational pharmaceutical companies. Its core expertise includes complex formulation challenges, analytical method development, and clinical trial material supply. UPM was acquired by Gregory Pharmaceutical Holdings in 2013, further strengthening its position in the pharmaceutical services market.